Search for a command to run...
Titan Bio-Tech Ltd. displays strong profitability metrics with a competitive PE ratio and reasonable debt levels, positioning it favorably against its peers. However, while growth potential is evident, the revenue trajectory raises some concerns, indicating the need for strategic focus in the coming quarters.
Stocks | CMP | Market Cap | P/E | ROCE (%) | Debt/Equity |
---|---|---|---|---|---|
Titan Bio-Tech Ltd. | ₹748.95 | ₹618.91Cr | 33.88 | 25.39% | 0.05 |
PIDILITIND | ₹3,124.70 | ₹1,58,937.55Cr | 76.64 | 30.55% | 0.02 |
SOLARINDS | ₹14,050.95 | ₹1,27,147.19Cr | 158.32 | 31.03% | 0.33 |
SRF | ₹2,897.20 | ₹85,880.25Cr | 60.69 | 12.83% | 0.43 |
GODREJIND | ₹1,224.65 | ₹41,240.33Cr | 217.46 | 7.21% | 3.61 |
FLUOROCHEM | ₹3,390.55 | ₹37,245.19Cr | 64.77 | 10.02% | 0.28 |
DEEPAKNTR | ₹1,788.15 | ₹24,389.11Cr | 88.23 | 17.00% | 0.22 |